How to Design Phase I Trials in Oncology

Phase 1 trials allow the assessment of the safety, tolerability and proof of mechanism of an investigational medical product (IMP), in monotherapy and in combination, in human trial participants. To achieve these objectives, preclinical data, trial design methodology and dose selection should be carefully considered and assimilated. In the following chapter the fundamental principles of phase 1 trial design will be outlined.